Loading...

Landec Corporation

LNDCNASDAQ
Healthcare
Drug Manufacturers - Specialty & Generic
$8.76
$-0.32(-3.52%)

Landec Corporation (LNDC) Stock Competitors & Peer Comparison

See (LNDC) competitors and their performances in Stock Market.

Peer Comparison Table: Drug Manufacturers - Specialty & Generic Industry

Detailed financial metrics including price, market cap, P/E ratio, and more.

SymbolPriceChange %Market CapP/E RatioEPSDividend Yield
LNDC$8.76-3.52%263.6M-4.04-$2.17N/A
ZTS$150.75-0.90%67.1B27.06$5.57+1.28%
TAK$14.31-1.14%45.2B62.24$0.23+4.12%
HLN$9.70-1.82%43.7B22.55$0.43+1.74%
TEVA$16.51-0.15%18.9B-14.36-$1.15N/A
ITCI$131.87+0.00%14B-180.64-$0.73N/A
NBIX$133.71+1.19%13.2B45.33$2.95N/A
RDY$14.70+0.20%12.3B18.63$0.79+0.50%
CTLT$63.48+0.00%11.5B-27.84-$2.28N/A
VTRS$9.26-1.59%10.9B-2.91-$3.18+5.19%
Showing 1 to 10 of 100 results
1

Stock Comparison

Select a stock to compare (requires JavaScript). Showing default comparison.

LNDC vs ZTS Comparison July 2025

LNDC plays a significant role within the Healthcare sector. Its performance reflects broader market trends and attracts considerable investor interest.

Comparing market capitalization, LNDC stands at 263.6M. In comparison, ZTS has a market cap of 67.1B. Regarding current trading prices, LNDC is priced at $8.76, while ZTS trades at $150.75.

To assess relative profitability and valuation, we examine the Return on Equity (ROE) and Price-to-Earnings (P/E) ratios.

LNDC currently has a P/E ratio of -4.04, whereas ZTS's P/E ratio is 27.06. In terms of profitability, LNDC's ROE is +2.28%, compared to ZTS's ROE of +0.51%. Regarding short-term risk, LNDC is more volatile compared to ZTS. This indicates potentially higher risk in terms of short-term price fluctuations for LNDC.Check ZTS's competition here

Stock price comparison of stocks in the Healthcare Sector

Loading...

Frequently Asked Questions

;